Search for: "*janssen v. U.s"
Results 101 - 120
of 147
Sort by Relevance
|
Sort by Date
5 Jun 2012, 2:24 am
Supreme Court decision in Brown v. [read post]
23 May 2012, 9:22 pm
Janssen Products, L.P. et al. v. [read post]
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
27 Jan 2012, 8:59 am
The case is Straka v. [read post]
24 Jan 2012, 6:34 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
27 Dec 2011, 9:56 am
Plaintiffs’ Legal Comm., 531 U.S. 341 (2001). [read post]
26 Dec 2011, 1:02 am
Euromotors West/The Auto Gallery, 2011 U.S. [read post]
22 Dec 2011, 11:59 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
18 Nov 2011, 4:32 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
10 Nov 2011, 7:16 pm
Ltd. v. [read post]
11 Aug 2011, 7:58 am
” Ortho-McNeil-Janssen Pharmaceuticals Inc. is accused of the following: Promoting Risperdal for uses that were neither approved by the U.S. [read post]
6 Jun 2011, 6:12 am
Sales of the drug fell to $527 million last year, according to a January earnings report.Risperdal Consta, the long-acting version of the antipsychotic drug, generated $1.5 billion in sales last year for J&J.The state’s case centered on drug-safety claims that J&J and Janssen made in November 2003 correspondence to about 700,000 doctors across the U.S., including more than 7,000 in South Carolina.The U.S. [read post]
23 May 2011, 9:59 pm
Alza Corp. et al. v. [read post]
20 May 2011, 8:53 am
Janssen, L.P., ___ F. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
23 Mar 2011, 5:02 am
Jurors also found that J&J warning label information on Risperdal was deceptive.The state’s case centered on drug-safety claims that New Brunswick, New Jersey-based J&J and Janssen made in November 2003 correspondence to about 700,000 doctors across the U.S., including 7,200 in South Carolina.The U.S. [read post]
22 Mar 2011, 5:08 am
The U.S. [read post]
11 Jan 2011, 11:07 pm
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post… [read post]
16 Dec 2010, 1:54 pm
Williams, 549 U.S. 346 (2007). [read post]
